Home / Methyldopa (Levorotatory) and Diuretics / Canada
CA ATC C02LB01 · updated 2 Nov 2026
Methyldopa (Levorotatory) and Diuretics shortage in Canada
Is there a Methyldopa (Levorotatory) and Diuretics shortage in Canada?
Yes. As of 2 Nov 2026, 2 Methyldopa (Levorotatory) and Diuretics products are reported short in Canada, the first since 10 Mar 2017. No return date has been given. Main reason: manufacturing problem.
Not reported short in any other country we track. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO METHAZIDE 15 (100 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO METHAZIDE 25 (100 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.